基于人工智能的液体定量与真实世界多中心新生血管性年龄相关性黄斑变性国家数据库中相关视觉结局的关联
本研究利用经验证的人工智能工具对452只未经治疗的新生血管性年龄相关性黄斑变性(nAMD)眼进行OCT液体分腔定量,分析其与12个月视觉结局的关联。结果显示,基线中心凹内视网膜液(IRF)和色素上皮脱离(PED)与较差的基线和最终视力相关,而中心凹下视网膜液(SRF)与更好的最终视力和更大的视力增益相关(均p<0.05)。
要点
- 基线中心凹IRF与较差的基线视力(44.7 vs 63.4字母)和最终视力(52.1 vs 69.1字母)相关。
- 基线中心凹SRF与更好的最终视力(67.1 vs 59.0字母)和更大的视力增益(+7.1 vs +1.9字母)相关。
- 预测视力增益在中心凹SRF、旁中心凹SRF、周边中心凹SRF和旁中心凹IRF中均更大(均p<0.05)。
核心结论
- 该真实世界研究描述了基于人工智能的液体动力学分析,并定义了与全国大型未经治疗nAMD眼队列12个月视觉结局相关的基线OCT患者特征。
研究设计与样本
- 真实世界、多中心、全国性队列研究,纳入452只未经治疗的nAMD眼,使用经验证的基于网络的工具收集人口学、视力、药物和注射次数数据,并使用经验证的人工智能工具在中心凹(1 mm)、旁中心凹(3 mm)和周边中心凹(6 mm)测量IRF、SRF和PED的液体定量(纳升,nL)。
主要发现
- 452只未经治疗nAMD眼在12个月内平均视力增益为+5.5字母,中位注射次数为7次。
- 基线中心凹IRF与较差的基线视力(44.7 vs 63.4字母)和最终视力(52.1 vs 69.1字母)相关。
- 基线中心凹SRF与更好的最终视力(67.1 vs 59.0字母)和更大的视力增益(+7.1 vs +1.9字母)相关。
- 基线PED与较差的基线视力(48.8 vs 57.3字母)和最终视力(55.1 vs 64.1字母)相关。
- 预测视力增益在中心凹SRF(+6.2 vs +0.6)、旁中心凹SRF(+6.9 vs +1.3)、周边中心凹SRF(+6.2 vs -0.1)和旁中心凹IRF(+7.4 vs +3.6)中更大(均p<0.05)。
关键数值与推荐
- 液体动力学分析显示中心凹SRF相对体积减少最大(-16.4 nL,-86.8%),其次为IRF(-17.2 nL,-84.7%)和PED(-19.1 nL,-28.6%)。
- 亚组分析显示注射次数更多的眼液体减少更明显。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To explore associations between artificial intelligence (AI)-based fluid compartment quantifications and 12 months visual outcomes in OCT images from a real-world, multicentre, national cohort of naïve neovascular age-related macular degeneration (nAMD) treated eyes. METHODS: Demographics, visual acuity (VA), drug and number of injections data were collected using a validated web-based tool. Fluid compartment quantifications including intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED) in the fovea (1 mm), parafovea (3 mm) and perifovea (6 mm) were measured in nanoliters (nL) using a validated AI-tool. RESULTS: 452 naïve nAMD eyes presented a mean VA gain of +5.5 letters with a median of 7 injections over 12 months. Baseline foveal IRF associated poorer baseline (44.7 vs 63.4 letters) and final VA (52.1 vs 69.1), SRF better final VA (67.1 vs 59.0) and greater VA gains (+7.1 vs +1.9), and PED poorer baseline (48.8 vs 57.3) and final VA (55.1 vs 64.1). Predicted VA gains were greater for foveal SRF (+6.2 vs +0.6), parafoveal SRF (+6.9 vs +1.3), perifoveal SRF (+6.2 vs -0.1) and parafoveal IRF (+7.4 vs +3.6, all p<0.05). Fluid dynamics analysis revealed the greatest relative volume reduction for foveal SRF (-16.4 nL, -86.8%), followed by IRF (-17.2 nL, -84.7%) and PED (-19.1 nL, -28.6%). Subgroup analysis showed greater reductions in eyes with higher number of injections. CONCLUSION: This real-world study describes an AI-based analysis of fluid dynamics and defines baseline OCT-based patient profiles that associate 12-month visual outcomes in a large cohort of treated naïve nAMD eyes nationwide.
引用
- Martin-Pinardel R, Izquierdo-Serra J, De Zanet S, et al. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database. Br J Ophthalmol. 2024. PMID: 36627173. doi:10.1136/bjo-2022-322297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。